InsidersTradesSigma
Follow the Enumeral Biomedical Holdings, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 6 January 2016 (Attribution). Among the most active insiders: VAN NOSTRAND ROBERT L. The full history is accessible without an account.
Analysts rate Enumeral Biomedical Holdings, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Enumeral Biomedical Holdings, Inc. 是一家专注于开发癌症免疫疗法的公司。它利用先进技术识别和开发针对免疫系统的药物。